Company Filing History:
Years Active: 2007-2010
Title: Péter Arányi: Innovator in Pharmaceutical Chemistry
Introduction
Péter Arányi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific enzymes and receptors.
Latest Patents
Arányi holds two patents that showcase his innovative work. The first patent involves compounds known as heterocyclic amides, which are useful as inhibitors of the dipeptylpeptidase-IV (DPP-IV) enzyme. This invention includes a detailed process for the preparation of these compounds and their intermediates. The second patent focuses on imidazoquinoline derivatives, which serve as adenosine A3 ligands. This invention encompasses a range of compounds, including their salts, solvates, and isomers, along with their pharmaceutical applications.
Career Highlights
Péter Arányi is currently associated with Sanofi-Aventis, a leading global biopharmaceutical company. His work at Sanofi-Aventis has allowed him to further his research and development efforts in the pharmaceutical sector.
Collaborations
Throughout his career, Arányi has collaborated with esteemed colleagues such as László Balázs and Sándor Bátori. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Péter Arányi is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. His patents reflect his commitment to innovation and his contributions to the scientific community.